Ricardo F Frausto1, Cynthia Wang1, Anthony J Aldave1. 1. The Jules Stein Eye Institute, David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, California, United States.
Abstract
PURPOSE: To comprehensively characterize human corneal endothelial cell (HCEnC) gene expression and age-dependent differential gene expression and to identify expressed genes mapped to chromosomal loci associated with the corneal endothelial dystrophies posterior polymorphous corneal dystrophy (PPCD)1, Fuchs endothelial corneal dystrophy (FECD)4, and X-linked endothelial dystrophy (XECD). METHODS: Total RNA was isolated from ex vivo corneal endothelium obtained from six pediatric and five adult donor corneas. Complementary DNA was hybridized to the Affymetrix GeneChip 1.1ST array. Data analysis was performed using Partek Genomics Suite software, and differentially expressed genes were validated by digital molecular barcoding technology. RESULTS: Transcripts corresponding to 12,596 genes were identified in HCEnC. Nine genes displayed the most significant differential expression between pediatric and adult HCEnC: CAPN6, HIST1H3A, HIST1H4E, and HSPA2 were expressed at higher levels in pediatric HCEnC, while ITGBL1, NALCN, PREX2, TAC1, and TMOD1 were expressed at higher levels in adult HCEnC. Analysis of the PPCD1, FECD4 and XECD loci demonstrated transcription of 53/95 protein-coding genes in the PPCD1 locus, 27/40 in the FECD4 locus, and 35/68 in the XECD locus. CONCLUSIONS: An analysis of the HCEnC transcriptome reveals the expression of almost 13,000 genes, with less than 1% mapped to chromosomal loci associated with PPCD1, FECD4, and XECD. At least nine genes demonstrated significant differential expression between pediatric and adult HCEnC, defining specific functional properties distinct to each age group. These data will serve as a resource for vision scientists investigating HCEnC gene expression and can be used to focus the search for the genetic basis of the corneal endothelial dystrophies for which the genetic basis remains unknown. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: To comprehensively characterize human corneal endothelial cell (HCEnC) gene expression and age-dependent differential gene expression and to identify expressed genes mapped to chromosomal loci associated with the corneal endothelial dystrophies posterior polymorphous corneal dystrophy (PPCD)1, Fuchs endothelial corneal dystrophy (FECD)4, and X-linked endothelial dystrophy (XECD). METHODS: Total RNA was isolated from ex vivo corneal endothelium obtained from six pediatric and five adult donor corneas. Complementary DNA was hybridized to the Affymetrix GeneChip 1.1ST array. Data analysis was performed using Partek Genomics Suite software, and differentially expressed genes were validated by digital molecular barcoding technology. RESULTS: Transcripts corresponding to 12,596 genes were identified in HCEnC. Nine genes displayed the most significant differential expression between pediatric and adult HCEnC: CAPN6, HIST1H3A, HIST1H4E, and HSPA2 were expressed at higher levels in pediatric HCEnC, while ITGBL1, NALCN, PREX2, TAC1, and TMOD1 were expressed at higher levels in adult HCEnC. Analysis of the PPCD1, FECD4 and XECD loci demonstrated transcription of 53/95 protein-coding genes in the PPCD1 locus, 27/40 in the FECD4 locus, and 35/68 in the XECD locus. CONCLUSIONS: An analysis of the HCEnC transcriptome reveals the expression of almost 13,000 genes, with less than 1% mapped to chromosomal loci associated with PPCD1, FECD4, and XECD. At least nine genes demonstrated significant differential expression between pediatric and adult HCEnC, defining specific functional properties distinct to each age group. These data will serve as a resource for vision scientists investigating HCEnC gene expression and can be used to focus the search for the genetic basis of the corneal endothelial dystrophies for which the genetic basis remains unknown. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Petra Liskova; Stephen J Tuft; Rhian Gwilliam; Neil D Ebenezer; Katerina Jirsova; Quincy Prescott; Radka Martincova; Marike Pretorius; Neil Sinclair; David L Boase; Margaret J Jeffrey; Panos Deloukas; Alison J Hardcastle; Martin Filipec; Shomi S Bhattacharya Journal: Hum Mutat Date: 2007-06 Impact factor: 4.878
Authors: Vivek S Yellore; Jeanette C Papp; Eric Sobel; M Ali Khan; Sylvia A Rayner; Debora B Farber; Anthony J Aldave Journal: Genet Med Date: 2007-04 Impact factor: 8.822
Authors: Eranga N Vithana; Patricio E Morgan; Vedam Ramprasad; Donald T H Tan; Victor H K Yong; Divya Venkataraman; Anandalakshmi Venkatraman; Gary H F Yam; Soumittra Nagasamy; Ricky W K Law; Rama Rajagopal; Chi P Pang; Govindsamy Kumaramanickevel; Joseph R Casey; Tin Aung Journal: Hum Mol Genet Date: 2007-11-16 Impact factor: 6.150
Authors: Jodhbir S Mehta; Eranga N Vithana; Donald T H Tan; Victor H K Yong; Gary H F Yam; Ricky W K Law; Wesley G W Chong; Calvin P Pang; Tin Aung Journal: Invest Ophthalmol Vis Sci Date: 2008-01 Impact factor: 4.799
Authors: Anthony J Aldave; Vivek S Yellore; Fei Yu; Nirit Bourla; Baris Sonmez; Andrew K Salem; Sylvia A Rayner; Kapil M Sampat; Charles M Krafchak; Julia E Richards Journal: Am J Med Genet A Date: 2007-11-01 Impact factor: 2.802
Authors: Viet Q Chau; Jiaxin Hu; Xin Gong; John D Hulleman; Rafael L Ufret-Vincenty; Frank Rigo; Thahza P Prakash; David R Corey; V Vinod Mootha Journal: Nucleic Acid Ther Date: 2020-03-23 Impact factor: 5.486
Authors: Wenlin Zhang; Ricardo Frausto; Doug D Chung; Christopher G Griffis; Liyo Kao; Angela Chen; Rustam Azimov; Alapakkam P Sampath; Ira Kurtz; Anthony J Aldave Journal: Invest Ophthalmol Vis Sci Date: 2020-07-01 Impact factor: 4.799